Design Therapeutics (DSGN) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Design Therapeutics (DSGN) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Design Therapeutics

· DSGN

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

786.651 M

-2.63%

General

Market Cap: $786.65M
Enterprise Value: $753.6M
Shares Outstanding: 62,460,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -32.91%
ROE: -34.03%
ROIC: -38.92%
Current Ratio: 18.86
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -1.93
P/S: —
P/FCF: —
P/B: 3.79
EV/EBITDA: -10.44

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $79.36M
Operating Income: -$79.36M
Net Profit: -$70.8M

Balance Sheet

Cash and Equivalents: $12.91M
Working Capital: $200.77M
Total Assets: $215.13M
Net Debt: -$10.88M
Total Liabilities: $13.27M
Total Equity: $201.86M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$55.08M
Cash Flow from Investing: $2.39M
Cash Flow from Financing: $45.89M
Free Cash Flow: -$55.14M
Capital Expenditures: $55K